How many clinical trials are studying Semaglutide Pen Injector?

6 recruiting trials in our tracked data involve Semaglutide Pen Injector.

What conditions is Semaglutide Pen Injector being studied for?

In our tracked recruiting trials, Semaglutide Pen Injector is being studied in trials for Obesity, COPD, Chronic Obstructive Pulmonary Disease.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 1 1 Phase 2 3 Phase 3 1 Phase 4 2

Condition	Trials
Obesity · Semaglutide Pen Injector for Obesity	3
COPD	1
Chronic Obstructive Pulmonary Disease	1
Diabetes type1	1
Glucose Intolerance After a Recent History of Gestational Diabetes	1
Hypertension	1
Interstitial Lung Disease	1
NAFLD	1
NASH	1
Obesity (Disorder)	1
Prostate Cancer	1
Pulmonary Hypertension	1
Sarcoidosis, Pulmonary	1
Type 2 diabetes	1

Feasibility of Semaglutide in Advanced Lung Disease
NCT05746039 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
Investigation of GLP1-Receptor Agonists in Men With Prostate Cancer Taking Androgen Deprivation Therapy
NCT06908694 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · 1 location
JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity
NCT06852391 · Phase: Phase 4 · Ages: 12 Years to 17 Years · Sex: All (male and female) · 1 location
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
NCT06411210 · Phase: Phase 2 · Ages: 18 Years to 30 Years · Sex: All (male and female) · 1 location
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
NCT05424003 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
NCT05569772 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female · 13 locations